A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases

被引:0
作者
Anghela Z. Paredes
J. Madison Hyer
Diamantis I. Tsilimigras
Amika Moro
Fabio Bagante
Alfredo Guglielmi
Andrea Ruzzenente
Sorin Alexandrescu
Eleftherios A. Makris
George A. Poultsides
Kazunari Sasaki
Federico N. Aucejo
Timothy M. Pawlik
机构
[1] The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center,Department of Surgery, Division of Surgical Oncology
[2] University of Verona,Department of Surgery
[3] Fundeni Clinical Institute,Department of Surgery
[4] Stanford University,Department of Surgery
[5] Cleveland Clinic Foundation,Department of General Surgery
[6] The Ohio State University,Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research
[7] Wexner Medical Center,undefined
来源
Annals of Surgical Oncology | 2020年 / 27卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5139 / 5147
页数:8
相关论文
共 112 条
[1]  
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin. 68 394-424
[2]  
Ferlay J(2017)Colon cancer survival in the United States by race and stage (2001–2009): findings from the CONCORD-2 study Cancer. 123 5014-5036
[3]  
Soerjomataram I(2018)Colorectal cancer liver metastases: a population-based study on incidence, management, and survival BMC Cancer. 18 78-318
[4]  
Siegel RL(1999)Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases Ann Surg. 230 309-126
[5]  
Torre LA(2019)RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases Ann Surg. 269 120-1172
[6]  
Jemal A(2004)The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases Arch Surg. 139 1168-681
[7]  
White A(2017)Validation of clinical risk score for colorectal liver metastases resected in a contemporary multicenter cohort HPB Oxford. 19 675-2763
[8]  
Joseph D(2011)Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy? Ann Surg Oncol. 18 2757-2582
[9]  
Rim SH(2016)A validated prognostic multigene expression assay for overall survival in resected colorectal cancer liver metastases Clin Cancer Res. 22 2575-729
[10]  
Johnson CJ(2015)Association between specific mutations in KRAS codon 12 and colorectal liver metastasis JAMA Surg. 150 722-288